Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia

An Open, Randomised, Parallel, Three Treatment Groups, Multicentre, Phase IV Study - in Real Life - to Compare the Change in Social Outcome of Quetiapine Fumarate (Seroquel®) Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia.

The purpose of this study is to compare efficacy of quetiapine fumarate combined with Cognitive Remediation Therapy (CRT) to conventional treatment by evaluating change in social outcome in patients with schizophrenia.

Inclusion Criteria:

• Signed informed consent
• Documented clinical diagnosis of schizophrenia or schizoaffective disorder for at least 2 years.
• Clinically stable and in an outpatient setting before entering the study (visit 1).

Exclusion Criteria:

• Use of clozapine and quetiapine within two months prior to visit 1.
• If total points are ≤ 55 Intelligence quotient (IQ) according to score of WAIS-III test at visit 1.